Eventide Asset Management, LLC holds a diversified book of 278 stocks worth $6.0B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Genedx Holdings Corp and trimmed Guardant Health Inc. Their largest long position is Guardant Health Inc at 4% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1442891/holdings"
Use Arkolith to show EVENTIDE ASSET MANAGEMENT, LLC's latest holdings, largest changes, and filing provenance.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Guardant Health Inc COM | $218.1M | 2.36M | 3.6% | ▼−5.9% Reduced · −149K sh | |
| 2 | Trane Technologies PLC SHS | $169.0M | 406.6K | 2.8% | ▲+0.8% Added · +3K sh | |
| 3 | Lam Research Corp COM NEW | $146.6M | 688.4K | 2.4% | ▲+2.9% Added · +19K sh | |
| 4 | Mirum Pharmaceuticals Inc COM | $130.1M | 1.41M | 2.2% | ▼−33% Reduced · −685K sh | |
| 5 | Targa Res Corp COM | $125.8M | 502.3K | 2.1% | ▲+4.5% Added · +22K sh | |
| 6 | Xometry Inc CLASS A COM | $120.8M | 2.96M | 2.0% | ▲+0.8% Added · +24K sh | |
| 7 | Ge Vernova Inc COM | $115.6M | 133.2K | 1.9% | ▼−29% Reduced · −54K sh | |
| 8 | Old Dominion Freight Line In COM | $115.5M | 591.7K | 1.9% | ▼−3.1% Reduced · −19K sh | |
| 9 | Scholar Rock Hldg Corp COM | $107.9M | 2.20M | 1.8% | ▼−9.6% Reduced · −234K sh | |
| 10 | Argenx SE SPONSORED ADR | $91.7M | 125.7K | 1.5% | ▲+3.6% Added · +4K sh | |
| 11 | ASML Hldg NV N Y REGISTRY SHS | $89.9M | 68.1K | 1.5% | ▲+1.9% Added · +1K sh | |
| 12 | Irhythm Holdings Inc COM | $89.8M | 760.8K | 1.5% | ▲+9.9% Added · +68K sh | |
| 13 | Insmed Inc COM PAR $.01 | $89.3M | 546.3K | 1.5% | ▲+13% Added · +63K sh | |
| 14 | Axsome Therapeutics Inc. COM | $87.8M | 519.6K | 1.5% | ▼−9.0% Reduced · −52K sh | |
| 15 | Vaxcyte Inc COM | $79.8M | 1.37M | 1.3% | ▲+50% Added · +457K sh | |
| 16 | Entergy Corp New COM | $76.5M | 682.8K | 1.3% | ▲+1.4% Added · +10K sh | |
| 17 | Vistra Corp COM | $74.0M | 492.7K | 1.2% | ▲+1.0% Added · +5K sh | |
| 18 | United Rentals Inc COM | $71.2M | 97.8K | 1.2% | ▲+1.9% Added · +2K sh | |
| 19 | Liberty Energy Inc COM CL A | $69.2M | 2.40M | 1.1% | ▲+22% Added · +433K sh | |
| 20 | Toast Inc CL A | $66.0M | 2.49M | 1.1% | ▲+0.1% Added · +3K sh | |
| 21 | Mettler Toledo International COM | $64.0M | 50.8K | 1.1% | ▲+1.0% Added · +493 sh | |
| 22 | Monolithic PWR Sys Inc COM | $63.4M | 58.2K | 1.0% | ▼−15% Reduced · −10K sh | |
| 23 | Royalty Pharma PLC SHS CLASS A | $62.6M | 1.31M | 1.0% | ▲+1.2% Added · +16K sh | |
| 24 | Nvent Elec PLC SHS | $61.6M | 523.6K | 1.0% | ▲+1.7% Added · +9K sh | |
| 25 | Williams Cos Inc COM | $60.5M | 832.2K | 1.0% | ▲+4.9% Added · +39K sh | |
| 26 | Nasdaq Inc COM | $60.2M | 711.8K | 1.0% | ▲+0.7% Added · +5K sh | |
| 27 | Generac Hldgs Inc COM | $59.9M | 306.8K | 1.0% | ▲+227% Added · +213K sh | |
| 28 | Beta Bionics Inc COM | $59.6M | 5.95M | 1.0% | ▲+19% Added · +951K sh | |
| 29 | D R Horton Inc COM | $59.0M | 430.9K | 1.0% | ▲+0.9% Added · +4K sh | |
| 30 | Kla Corp COM NEW | $57.8M | 39.6K | 1.0% | ▼−12% Reduced · −6K sh | |
| 31 | Belite Bio Inc SPONSORED ADS | $57.0M | 357.6K | 0.9% | ▼−6.6% Reduced · −25K sh | |
| 32 | Lattice Semiconductor Corp COM | $56.6M | 611.1K | 0.9% | ▼−1.6% Reduced · −10K sh | |
| 33 | Prologis Inc. COM | $56.1M | 427.1K | 0.9% | ▲+1.5% Added · +6K sh | |
| 34 | Transmedics Group Inc COM | $54.5M | 548.8K | 0.9% | ▲+0.1% Added · +557 sh | |
| 35 | DT Midstream Inc COMMON STOCK | $54.1M | 402.0K | 0.9% | ▲+1.8% Added · +7K sh | |
| 36 | Nisource Inc COM | $53.3M | 1.14M | 0.9% | ▲+0.9% Added · +10K sh | |
| 37 | Kymera Therapeutics Inc COM | $52.2M | 626.9K | 0.9% | ▲+0.1% Added · +495 sh | |
| 38 | RB Global Inc COM | $50.6M | 528.1K | 0.8% | ▲+0.1% Added · +548 sh | |
| 39 | Waste Connections Inc COM | $50.3M | 309.9K | 0.8% | ▼−0.1% Reduced · −184 sh | |
| 40 | Oreilly Automotive Inc COM | $49.8M | 539.9K | 0.8% | ▼−0.4% Reduced · −2K sh | |
| 41 | Quanta Svcs Inc COM | $49.0M | 89.4K | 0.8% | ▲+0.5% Added · +454 sh | |
| 42 | Collegium Pharmaceutical Inc COM | $47.1M | 1.42M | 0.8% | ▼−24% Reduced · −452K sh | |
| 43 | Apogee Therapeutics Inc COM | $46.9M | 557.4K | 0.8% | ▲+28% Added · +121K sh | |
| 44 | Vulcan Matls Co COM | $46.2M | 169.6K | 0.8% | ▲+0.1% Added · +205 sh | |
| 45 | Nvidia Corporation COM | $44.7M | 259.4K | 0.7% | ▲+8.4% Added · +20K sh | |
| 46 | Eastgroup Pptys Inc COM | $43.6M | 235.7K | 0.7% | ▼−0.2% Reduced · −428 sh | |
| 47 | Ionis Pharmaceuticals Inc COM | $43.2M | 575.0K | 0.7% | —Held | |
| 48 | Steris PLC SHS USD | $43.0M | 194.6K | 0.7% | ▲+2.2% Added · +4K sh | |
| 49 | Palo Alto Networks Inc COM | $40.4M | 252.2K | 0.7% | ▲+73% Added · +106K sh | |
| 50 | Lowes Cos Inc COM | $40.2M | 170.6K | 0.7% | ▲~0% Added · +7 sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 278 | $6.0B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 268 | $6.4B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 240 | $6.1B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 237 | $5.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 217 | $5.0B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 204 | $5.5B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 180 | $5.8B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 | 161 | $5.8B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 157 | $6.4B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 20, 2024 | 152 | $6.1B | 13F-HR/A |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 155 | $5.6B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 15, 2023 | 139 | $5.9B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 149 | $5.5B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 13, 2023 | 143 | $5.1B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 138 | $5.1B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 136 | $4.7B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 136 | $6.4B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 146 | $7.8B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 152 | $7.6B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 152 | $7.4B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 156 | $6.7B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 158 | $6.5B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 142 | $5.1B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.